8-K/A XBRL

FORM 8-K/A

Company: Protagenic Therapeutics, Inc.\new
Filed: July 12, 2016
Period of Report: February 12, 2016
Accession Number: 0001437749-16-035178

View Document ↗ View on SEC.gov ↗